124 related articles for article (PubMed ID: 18930085)
1. Liposomal glycosphingolipids activate natural killer T cell-mediated immune responses through the endosomal pathway.
Inoue J; Ideue R; Takahashi D; Kubota M; Kumazawa Y
J Control Release; 2009 Jan; 133(1):18-23. PubMed ID: 18930085
[TBL] [Abstract][Full Text] [Related]
2. Recognition of bacterial glycosphingolipids by natural killer T cells.
Kinjo Y; Wu D; Kim G; Xing GW; Poles MA; Ho DD; Tsuji M; Kawahara K; Wong CH; Kronenberg M
Nature; 2005 Mar; 434(7032):520-5. PubMed ID: 15791257
[TBL] [Abstract][Full Text] [Related]
3. Effective stimulation of invariant natural killer T cells by oligomannose-coated liposomes.
Ishii M; Kojima N
Int Immunopharmacol; 2013 Apr; 15(4):685-92. PubMed ID: 23535021
[TBL] [Abstract][Full Text] [Related]
4. Activation state and intracellular trafficking contribute to the repertoire of endogenous glycosphingolipids presented by CD1d [corrected].
Muindi K; Cernadas M; Watts GF; Royle L; Neville DC; Dwek RA; Besra GS; Rudd PM; Butters TD; Brenner MB
Proc Natl Acad Sci U S A; 2010 Feb; 107(7):3052-7. PubMed ID: 20133624
[TBL] [Abstract][Full Text] [Related]
5. Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids.
Paget C; Mallevaey T; Speak AO; Torres D; Fontaine J; Sheehan KC; Capron M; Ryffel B; Faveeuw C; Leite de Moraes M; Platt F; Trottein F
Immunity; 2007 Oct; 27(4):597-609. PubMed ID: 17950005
[TBL] [Abstract][Full Text] [Related]
6. Cell wall glycosphingolipids of Sphingomonas paucimobilis are CD1d-specific ligands for NKT cells.
Sriram V; Du W; Gervay-Hague J; Brutkiewicz RR
Eur J Immunol; 2005 Jun; 35(6):1692-701. PubMed ID: 15915536
[TBL] [Abstract][Full Text] [Related]
7. Innate immune responses involving natural killer and natural killer T cells promote liver regeneration after partial hepatectomy in mice.
Hosoya S; Ikejima K; Takeda K; Arai K; Ishikawa S; Yamagata H; Aoyama T; Kon K; Yamashina S; Watanabe S
Am J Physiol Gastrointest Liver Physiol; 2013 Feb; 304(3):G293-9. PubMed ID: 23086918
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cell internalization of α-galactosylceramide from CD8 T cells induces potent antitumor CD8 T-cell responses.
Choi DH; Kim KS; Yang SH; Chung DH; Song B; Sprent J; Cho JH; Sung YC
Cancer Res; 2011 Dec; 71(24):7442-51. PubMed ID: 22028323
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor-dependent IL-12 production by dendritic cells is required for activation of natural killer cell-mediated Type-1 immunity induced by Chrysanthemum coronarium L.
Tanaka S; Koizumi S; Masuko K; Makiuchi N; Aoyagi Y; Quivy E; Mitamura R; Kano T; Ohkuri T; Wakita D; Chamoto K; Kitamura H; Nishimura T
Int Immunopharmacol; 2011 Feb; 11(2):226-32. PubMed ID: 21144920
[TBL] [Abstract][Full Text] [Related]
10. Potentiation of murine innate immunity by alpha-galacturonosyl-type glycosphingolipids isolated from Sphingomonas yanoikuyae and S. terrae.
Kubota M; Takimoto H; Kaneko M; Inoue J; Kumazawa Y
Immunopharmacol Immunotoxicol; 2009; 31(3):363-9. PubMed ID: 19555191
[TBL] [Abstract][Full Text] [Related]
11. Essential role of Toll-like receptors for dendritic cell and NK1.1(+) cell-dependent activation of type 1 immunity by Lactobacillus pentosus strain S-PT84.
Koizumi S; Wakita D; Sato T; Mitamura R; Izumo T; Shibata H; Kiso Y; Chamoto K; Togashi Y; Kitamura H; Nishimura T
Immunol Lett; 2008 Oct; 120(1-2):14-9. PubMed ID: 18620001
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of lipid antigen presentation in dendritic cells by HIV-1 Vpu interference with CD1d recycling from endosomal compartments.
Moll M; Andersson SK; Smed-Sörensen A; Sandberg JK
Blood; 2010 Sep; 116(11):1876-84. PubMed ID: 20530791
[TBL] [Abstract][Full Text] [Related]
13. A Novel Glycolipid Antigen for NKT Cells That Preferentially Induces IFN-γ Production.
Birkholz AM; Girardi E; Wingender G; Khurana A; Wang J; Zhao M; Zahner S; Illarionov PA; Wen X; Li M; Yuan W; Porcelli SA; Besra GS; Zajonc DM; Kronenberg M
J Immunol; 2015 Aug; 195(3):924-33. PubMed ID: 26078271
[TBL] [Abstract][Full Text] [Related]
14. NKT cell activation by Leishmania mexicana LPG: Description of a novel pathway.
Zamora-Chimal J; Fernández-Figueroa EA; Ruiz-Remigio A; Wilkins-Rodríguez AA; Delgado-Domínguez J; Salaiza-Suazo N; Gutiérrez-Kobeh L; Becker I
Immunobiology; 2017 Feb; 222(2):454-462. PubMed ID: 27523746
[TBL] [Abstract][Full Text] [Related]
15. Role of marginal zone B lymphocytes in invariant NKT cell activation.
Bialecki E; Paget C; Fontaine J; Capron M; Trottein F; Faveeuw C
J Immunol; 2009 May; 182(10):6105-13. PubMed ID: 19414762
[TBL] [Abstract][Full Text] [Related]
16. Rapid interferon-gamma release from natural killer cells induced by a streptococcal commensal.
Bouwer AL; Saunderson SC; Dunn AC; Lester KL; Crowley LR; Jack RW; McLellan AD
J Interferon Cytokine Res; 2013 Aug; 33(8):459-66. PubMed ID: 23659669
[TBL] [Abstract][Full Text] [Related]
17. Design of natural killer T cell activators: structure and function of a microbial glycosphingolipid bound to mouse CD1d.
Wu D; Zajonc DM; Fujio M; Sullivan BA; Kinjo Y; Kronenberg M; Wilson IA; Wong CH
Proc Natl Acad Sci U S A; 2006 Mar; 103(11):3972-7. PubMed ID: 16537470
[TBL] [Abstract][Full Text] [Related]
18. Scavenger receptors target glycolipids for natural killer T cell activation.
Freigang S; Landais E; Zadorozhny V; Kain L; Yoshida K; Liu Y; Deng S; Palinski W; Savage PB; Bendelac A; Teyton L
J Clin Invest; 2012 Nov; 122(11):3943-54. PubMed ID: 23064364
[TBL] [Abstract][Full Text] [Related]
19. Activation of invariant Natural Killer T lymphocytes in response to the α-galactosylceramide analogue KRN7000 encapsulated in PLGA-based nanoparticles and microparticles.
Macho Fernandez E; Chang J; Fontaine J; Bialecki E; Rodriguez F; Werkmeister E; Krieger V; Ehret C; Heurtault B; Fournel S; Frisch B; Betbeder D; Faveeuw C; Trottein F
Int J Pharm; 2012 Feb; 423(1):45-54. PubMed ID: 21575695
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel glycolipid ligands activating a sulfatide-reactive, CD1d-restricted, type II natural killer T lymphocyte.
Rhost S; Löfbom L; Rynmark BM; Pei B; Månsson JE; Teneberg S; Blomqvist M; Cardell SL
Eur J Immunol; 2012 Nov; 42(11):2851-60. PubMed ID: 22777932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
